Mycobacterium tuberculosis prosthetic joint infections: A case series and literature review
Uhel F, Corvaisier G, Poinsignon Y, Chirouze C, Beraud G, Grossi O, Varache N, Arvieux C, et al. (10 authors)
The Journal of infection · 2018-08
Abstract
Objectives We aimed to characterize diagnosis, management, and outcome of Mycobacterium tuberculosis prosthetic joint infections (PJI). Methods Cases of M. tuberculosis PJI documented in 7 referral French centers were retrospectively reviewed. Data were collected from medical files on a standardized questionnaire. We performed a literature review using the keywords 'prosthetic joint', and 'tuberculosis'. Results During years 1997-2016, 13 patients (8 males, 5 females, median age 79 years [range, 60-86]) had documented M. tuberculosis PJI, involving hip (n = 6), knee (n = 6), or shoulder (n = 1). Median time from arthroplasty to diagnosis was 9 years [0.4-20]. The diagnosis was obtained on joint aspirates (n = 9), or synovial tissue (n = 4). PCR was positive in all cases tested (5/5). Median duration of antituberculosis treatment was 14 months [6-32]). Nine patients underwent surgery: debridement (n = 4), resection arthroplasty (n = 3), and revision arthroplasty (1-stage exchange, n = 2). PJI was controlled in 12 patients. Seventeen additional cases of documented M. tuberculosis PJI have been reported, with a favorable outcome in 79% (11/14) of patients with no surgery, 85% (11/13) with debridement, 86% (19/22) with revision arthroplasty, and 81% (17/21) with resection (NS). Conclusions M. tuberculosis PJI can be controlled with prolonged antituberculosis treatment in most cases, with or without surgical treatment.
MeSH terms
- Joints
- Humans
- Mycobacterium tuberculosis
- Tuberculosis
- Prosthesis-Related Infections
- Anti-Bacterial Agents
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Retrospective Studies
- Aged
- Aged, 80 and over
- Middle Aged
- Disease Management
- Female
- Male
- Surveys and Questionnaires
- Arthroplasty, Replacement, Shoulder